Epilepsy GTX is a startup based in the United Kingdom, 2 tracked investors.
Epilepsy GTX is a company headquartered in the United Kingdom. Brouky records 2 investors associated with the company.
EpilepsyGTx is a late preclinical-stage biotech developing gene therapies to provide seizure freedom for patients with focal refractory epilepsy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.